The safety of multiple oral immunotherapy in phase one studies at a single center

por Dominguez, TLR, Mehrotra, A, Wilson, S, Winterroth, L, Blakemore, A, Sampson, K, Nadeau, K
Publicado 2013

A080 A COMPREHENSIVE CHARACTERIZATION OF POST-COVID-19 SYNDROME IN A DIVERSE POPULATION

por Jia, X., Cao, S., Lee, A., Chinthrajah, S., Yoffe, C., Boyd, S., Pinsky, B., Nadeau, K.
Publicado 2021

M019 COVID-19 VACCINE-ASSOCIATED ANAPHYLAXIS: BASOPHIL ACTIVATION IN A SPECIFIC IGE AND IGG NEGATIVE PATIENT

por Jiang, S., Smith, E., Vo, V., Sampath, V., Snow, T., Shah, M., Heider, A., Akdis, C., Nadeau, K.
Publicado 2021

A050 THE IMPACT OF COVID-19 AND DISEASE CONTROL MEASURES ON PEDIATRIC FOOD ALLERGY PARENTS/CAREGIVERS AND PATIENTS

por Warren, C., Chinthrajah, S., Newmark, P., Herbert, L., Fox, S., Nadeau, K., Sharma, H., Assa'ad, A., Tobin, M., Gupta, R.
Publicado 2020

Changes in antigen-specific T cell number and function during oral desensitization in cow’s milk allergy enabled with omalizumab

por Bedoret, D, Singh, A K, Shaw, V, Hoyte, E G, Hamilton, R, DeKruyff, R H, Schneider, L C, Nadeau, K C, Umetsu, D T
Publicado 2012